Dental research can be thought of as a continuum of clinical observations that are dissected in the laboratory with answers that can be brought back to the clinic to change patient management. We believe this is the case for the use of adhesive systems and outcomes of dental treatment. Clinical observations related to negative outcomes have been tested in the laboratory and solutions have been proposed, with more precise implementation of these solutions possible when genomic approaches are added. Here we elaborate on this process based on the observations that lead to an attempt to inactivate metalloproteinase activity by dentin crosslinking.
BauvoisB.2012. New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim Biophys Acta. 1825(1):29–36.
2.
McGuireJDGorskiJPDusevichVWangYWalkerMP.2014. Type IV collagen is a novel DEJ biomarker that is reduced by radiotherapy. J Dent Res. 93(10):1028–1034.
3.
Menezes-SilvaRKhaliqSDeeleyKLetraAVieiraAR.2012. Genetic susceptibility to periapical disease: conditional contribution of MMP2 and MMP3 genes to the development of periapical lesions and healing response. J Endod. 38(5):604–607.
4.
MünchowEABottinoMC.2017. Recent advances in adhesive bonding: the role of biomolecules, nanocompounds, and bonding strategies in enhancing resin bonding to dental substrates. Curr Oral Health Rep. 4(3):215–227.
5.
VieiraARSilvaMBSouzaKKAFilhoAVARosenblattAModestoA.2017. A pragmatic study shows failure of dental composite fillings is genetically determined: a contribution to the discussion on dental amalgams. Front Med (Lausanne). 4:186.
